Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome

Methyl-orvinol could become a promising drug candidate in chronic therapy of functional GI diseases such as IBS-D.